The last two decades have heralded a remarkable increase in our understanding of the genetic basis of disease and the endogenous mechanisms responsible for the repair of genomic DNA and the processing of RNA. Targeted gene repair is a powerful yet controversial technique developed to direct base changes in chromosomal genes, while RNA repair is an emerging strategy to alter the coding content of messenger RNAs. This Perspective series examines the inspired techniques for facilitating the simple correction of genetic defects in what would represent a major shift in the paradigm of clinical science, and the hurdles that need to be overcome in order to make clinical use of molecular therapeutics. Human genetic information is encoded in the sequences of nucleic acids found inside our cells. During the past two decades, it has become increasingly apparent that such instructions are not fixed, but rather that molecular processes exist that can revise them. Recently, a number of investigators have been exploring whether the ability to revise RNA or DNA sequences can be used to repair mutant genetic instructions, to treat inherited disorders such as cystic fibrosis and sickle cell disease, as well as to revise pathogenic genes associated with cancers and infectious diseases. This repair approach has received increasing attention because of the safety and efficacy issues encountered with more traditional gene therapy strategies where additional copies of therapeutic genes are delivered to and expressed in transduced cells. Most notably, the recent observation that retroviral gene transfer apparently induced leukemia in two children treated for X-linked SCIDs has raised significant safety concerns for traditional gene add-back strategies (1). In contrast to the traditional approach to gene therapy, genetic repair strategies attempt to directly correct endogenous genetic mistakes rather than deliver extra copies of genes to cells. Thus by analogy, genetic repair methods are similar to word processors that correct misspelled words within their intended written context, whereas gene add-back approaches are similar to editors who prepare corrected versions of defective sentences and then randomly insert them into the text without amending the original written mistake. Genetic repair strategies may have significant therapeutic and safety advantages over traditional gene therapy approaches for the treatment of many genetic disorders. Firstly, because the mutant genetic instructions are directly repaired, the corrected RNAs and/or DNAs will be maintained in their native sequence context and be regulated by their endogenous regulatory machinery. Secondly, in the instance where the mutant gene encodes a deleterious or dominant-negative mutant protein, repair of the mutant should simultaneously engender the regulated production of the wild-type protein while eliminating or reducing expression of the deleterious gene product. Finally, genetic repair strategies attempt to repair defective instructions in a site-specific manner. Therefore, once adequately developed, these strategies will result in less random mutagenesis of the genome and lead to fewer mutagenic side effects than do methods that randomly insert genes into the genome (1). In this Perspective series, six articles will update the reader on the progress toward and the hurdles that remain for developing such genetic repair strategies. The first half of the series will focus on approaches to RNA repair, while the latter will describe methods for DNA repair. As therapeutic modalities, RNA and DNA repair have different advantages and weaknesses. For example, RNA repair may represent a safer approach to genetic correction than DNA repair because the revision of unintended target RNA will not result in permanent genetic change within a cell since RNAs undergo continual turnover in vivo. However, the limited half-life of the amended instructions also necessitates that RNA repair strategies have to continually repair the mutant RNAs emerging from mutant DNA. By contrast, DNA repair will amend the cell’s genetic blueprint, and such repair need occur only once to permanently correct the products expressed from the repaired gene in the treated cell and its progeny. However, since any revised DNA will be stably maintained and propagated, the specificity of DNA repair is a major safety consideration because genes that are unintentionally revised will also be maintained and propagated.
Read full abstract
Oct 1, 2003
Angel P Tabancay + 6
Open Access
